Neonatal size unaffected by gestational diabetes drugs

March 8, 2013
Neonatal size unaffected by gestational diabetes drugs
Women with gestational diabetes mellitus treated with metformin or insulin have similar changes in markers of metabolic status and no differences in offspring birth weight, according to a study published in the March issue of Diabetes Care.

(HealthDay)—Women with gestational diabetes mellitus treated with metformin or insulin have similar changes in markers of metabolic status and no differences in offspring birth weight, according to a study published in the March issue of Diabetes Care.

Helen L. Barrett, M.B.B.S., from the University of Queensland in Herston, Australia, and colleagues examined the association between circulating maternal and neonatal markers of metabolic status (glucose, lipids, C-reactive protein) with infant size at birth in women with gestational diabetes mellitus, where 236 women had been randomly assigned to metformin and 242 had been randomly assigned to insulin.

The researchers found that women treated with metformin had a significantly greater increase in triglycerides at 36 weeks of gestation (21.93 versus 9.69 percent). There were no other differences between treatment groups for maternal or neonatal metabolic markers or neonatal anthropometry. After adjusting for possible confounding variables, including maternal , a birth weight in the >90th percentile was associated with markers of , maternal , and triglycerides, while a birth weight in the <10th percentile was associated with triglycerides.

"There were few differences in circulating maternal and neonatal markers of metabolic status and no differences in measures of anthropometry between the offspring of women treated with metformin and the offspring of women treated with insulin," Barrett and colleagues conclude.

Explore further: Gestational diabetes, obesity impact pregnancy outcomes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Gestational diabetes, obesity impact pregnancy outcomes

March 2, 2012
(HealthDay) -- Women with gestational diabetes mellitus (GDM) who are obese have significantly higher odds of adverse pregnancy outcomes, according to findings from the multinational Hyperglycemia and Adverse Pregnancy Outcome ...

Excess maternal weight before and during pregnancy can result in larger babies

May 22, 2012
Excess weight in pregnant women, both before pregnancy and gained during pregnancy, is the main predictor of whether mothers will have larger than average babies, which can result in increased risk of cesarean section or ...

Maternal glycemic status linked to epigenetic changes

March 9, 2012
(HealthDay) -- Maternal glycemic status and adiponectin levels are linked to epigenetic changes in the adiponectin gene (ADIPOQ), according to a study published online March 6 in Diabetes.

Overweight baby girls at increased risk for cardiovascular disease and diabetes in adulthood

March 29, 2012
Heavier female babies are more likely to develop diabetes and related metabolic risks when they grow up compared with their male counterparts, according to a recent study accepted for publication in The Endocrine Society's ...

Study suggests antipsychotic drugs during pregnancy linked to increased risk of gestational diabetes

July 2, 2012
A study that examined maternal use of antipsychotic drugs during pregnancy suggests that these medications may be linked to an increased risk of gestational diabetes, according to a report in the July issue of Archives of ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.